|Taking Mefenamic acid with alcohol increases the risk of stomach bleeding.
|Cyclon UT 10 mg/250 mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
|Cyclon UT 10 mg/250 mg Tablet is probably unsafe to use during lactation. \nLimited human data suggest that the drug could represent a significant risk to the baby.
|Common Side Effect
|Nausea, Vomiting, Diarrhoea, Indigestion, Dryness in mouth, Loss of appetite, Sleepiness, Weakness, Nervousness, Blurred vision, Heartburn.
|How to Use
|Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cyclon UT 10 mg/250 mg Tablet is to be taken with food.This will help to avoid stomach upset.
|Cyclon UT 10 mg/250 mg Tablet may make you feel dizzy, drowsy or affect your vision. Do not drive until your vision is clear.
|Cyclon UT 10 mg/250 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Cyclon UT 10 mg/250 mg Tablet may be needed. Please consult your doctor.Use of Cyclon UT 10 mg/250 mg Tablet is not recommended in patients with severe kidney disease.
|Cyclon UT 10 mg/250 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Cyclon UT 10 mg/250 mg Tablet may be needed. Please consult your doctor.
|Mechanism of action
|Cyclon UT 10 mg/250 mg Tablet is a combination of two medicines: dicyclomine and mefenamic acid which relieve abdominal pain. Dicyclomine is an anticholinergic which works by relaxing the muscles in the stomach and gut (intestine). It stops sudden muscle contractions (spasms). By doing this, it relieves cramps, pain, bloating, and discomfort. Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) which works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).